Denise Pedulla Appointed as Chief Legal Officer at Conformis

Conformis Inc. has welcomed Denise Pedulla as its chief legal officer and corporate secretary.
 
“We are pleased to announce the addition of Denise Pedulla as chief legal officer and corporate secretary. Her strong public company experience and leadership capabilities will help support our growth strategy and further strengthens our executive team,” said Mark Augusti, president and CEO. “I look forward to the contributions she will make as a member of the Conformis team.”
 
Prior to joining Conformis, Pedulla served as general counsel and corporate secretary for NeoGenomics, a global clinical laboratory, pharmaceutical services, and bioinformatics company. During her more than five-year tenure at NeoGenomics, Pedulla’s responsibilities included overseeing mergers and acquisitions, commercial contracting, SEC compliance, IP protection and litigation, global regulatory compliance, and all other aspects of legal support. Prior to that she held various leadership roles at Berkeley Research Group, Orthofix International N.V., and Fresenius Medical Care NA.

Pedulla earned a master’s degree in public health from Harvard University, her Juris Doctor from Suffolk University School of Law, and her bachelor of science degree in nursing and psychology from Boston College. 
 
As an inducement to Pedulla agreeing to employment with the company, the Board of Directors granted her 450,000 shares of common company stock, and stock options to acquire 450,000 shares of stock. The restricted stock units and stock options both vest in various staggered installments over an eight-year period subject to service by Pedulla through the applicable vesting dates.
 
Conformis is a medical technology company focused on advancing orthopedic patient care. Its product portfolio is designed to maximize surgeon and patient choice by offering fully personalized solutions through its Image-to-Implant Platinum ServicesSM Program as well as data-informed, standardized solutions that combine many benefits of personalization with the convenience and flexibility of an off-the-shelf system. Conformis’ sterile, just-in-time, Surgery-in-a-Box delivery system is available with all of its implants and personalized, single-use instruments. Conformis owns or exclusively in-licenses issued patents and pending patent applications that cover personalized implants and patient-specific instrumentation for all major joints.